| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/18/2006 | US20060104980 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | US20060104971 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 05/18/2006 | US20060104964 Recombinant sequence, its preparation and use |
| 05/18/2006 | US20060104963 Use of transfected stem cell population expressing an antiangiogenic fragment of human tryptophanyl tRNA synthetase (TrpRS); cell-based gene therapy |
| 05/18/2006 | US20060104961 Mechanisms of myoblast transfer in treating heart failure |
| 05/18/2006 | US20060104956 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer |
| 05/18/2006 | US20060104954 Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
| 05/18/2006 | US20060104953 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof |
| 05/18/2006 | US20060104952 Genomic barrier to viral disease |
| 05/18/2006 | US20060104950 Methods of Tranducing genes into T cells |
| 05/18/2006 | US20060104949 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 05/18/2006 | US20060104905 Methods of screening agents for activity using teleosts |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | US20060102479 Simultaneous multiple color standardization; automated length measurement |
| 05/18/2006 | DE19810349B4 Chitindeacetylasegen, Vektor, der dieses Gen enthält und Transformanten Chitindeacetylasegen, vector containing this gene and transformants |
| 05/18/2006 | DE19608751B4 Verwendung eines Adeno-assoziierten Virus-Vektors zur Steigerung der Immunogenität von Zellen Using an adeno-associated virus vector to enhance the immunogenicity of cells |
| 05/18/2006 | DE10063879B4 Nucleinsäuren, die vacuoläre Invertasen codieren, Pflanzenzellen und Pflanzen, die diese enthalten sowie ihre Verwendung Nucleic acids encoding the vacuolar invertase, plant cells and plants containing them and their use |
| 05/18/2006 | CA2629751A1 Antimicrobial peptides |
| 05/18/2006 | CA2595757A1 Insecticidal polypeptides and methods of use thereof |
| 05/18/2006 | CA2590245A1 Ladder assembly and system for generating diversity |
| 05/18/2006 | CA2588088A1 Derivation of embryonic stem cells |
| 05/18/2006 | CA2587494A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 05/18/2006 | CA2587469A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | CA2587449A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/18/2006 | CA2587369A1 Mutant interferon .alpha. proteins and use thereof |
| 05/18/2006 | CA2587173A1 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 05/18/2006 | CA2586987A1 Methods and compositions for treating cellular proliferative diseases |
| 05/18/2006 | CA2586913A1 Targeted innate immunity |
| 05/18/2006 | CA2586811A1 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 05/18/2006 | CA2586701A1 Lna oligonucleotides and the treatment of cancer |
| 05/18/2006 | CA2586661A1 Antibodies against tenascin-c |
| 05/18/2006 | CA2586532A1 Compositions and methods for purifying nucleic acids from stabilization reagents |
| 05/18/2006 | CA2586486A1 Leucine-rich repeat (lrr) motif containing proteins |
| 05/18/2006 | CA2586378A1 Method of evaluating plant protection |
| 05/18/2006 | CA2586356A1 Anti-properdin antibodies, and methods for making and using same |
| 05/18/2006 | CA2586006A1 Nucleic acid enzyme light-up sensor utilizing invasive dna |
| 05/18/2006 | CA2585927A1 Polypeptides that bind baff and/or april |
| 05/18/2006 | CA2585561A1 Molecular indicators of breast cancer prognosis and prediction of treatment response |
| 05/18/2006 | CA2585404A1 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | CA2585235A1 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | CA2584719A1 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | CA2582956A1 Pm29 and lea3 promoters and use in expression of transgenic genes in plants |
| 05/18/2006 | CA2580084A1 T cell proteins and nucleotides encoding the same |
| 05/18/2006 | CA2565287A1 Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi |
| 05/18/2006 | CA2488113A1 A non-human animal alzheimer's disease model and uses thereof |
| 05/17/2006 | EP1657313A2 Methods and reagents for preserving RNA in cell and tissue samples |
| 05/17/2006 | EP1657311A1 Method of evaluating compound efficacious in treating obesity |
| 05/17/2006 | EP1657309A1 Viral production process |
| 05/17/2006 | EP1657308A1 Enhanced expression in a plant plastid |
| 05/17/2006 | EP1657307A1 Oligonucleotides that induce the secretion of GM-CSF |
| 05/17/2006 | EP1657306A1 Gene silencing using sense DNA and antisense RNA hybrid constructs coupled to peptides facilitating the uptake into cells |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1657254A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 05/17/2006 | EP1657253A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/17/2006 | EP1657252A2 PGC-1, a novel brown fat PPAR gamma coactivator |
| 05/17/2006 | EP1657248A2 Vaccine for preventing and treating porcine progressive atrophic rhinitis |
| 05/17/2006 | EP1656950A1 Immunotoxins directed against CD33 related surface antigens |
| 05/17/2006 | EP1656458A2 Human autism susceptibility gene and uses thereof |
| 05/17/2006 | EP1656453A2 Eukaryotic expression systems for expression of inhibitory rna in multiple intracellular compartments |
| 05/17/2006 | EP1656452A2 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 05/17/2006 | EP1656450A1 Cephalosporin c acylase mutant and method for preparing 7-aca using same |
| 05/17/2006 | EP1656449A1 Fatty acid desaturases from primula |
| 05/17/2006 | EP1656443A2 Solid phase cell lysis and capture platform |
| 05/17/2006 | EP1656392A2 Tie1-binding ligands |
| 05/17/2006 | EP1656389A1 A method for cleaving proteins |
| 05/17/2006 | EP1656012A2 Plants resistant to cytoplasm-feeding parasites |
| 05/17/2006 | EP1599089A4 Efficient gene silencing in plants using short dsrna sequences |
| 05/17/2006 | EP1573313A4 Transgenic mice expressing human cd20 and/or cd16 |
| 05/17/2006 | EP1551980A4 Stabilized naked dna compositions |
| 05/17/2006 | EP1513958A4 Compositions and methods for detecting hepatitis b virus |
| 05/17/2006 | EP1424887A4 In planta transformation by embryo imbibition of agrobacterium |
| 05/17/2006 | EP1421216A4 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group |
| 05/17/2006 | EP1421183A4 Methods for improving seed and grain characteristics |
| 05/17/2006 | EP1325126B1 Human ion-exchanger proteins and polynucleotides encoding the same |
| 05/17/2006 | EP1296711B1 Hpv-e7 for human papilloma virus treatment |
| 05/17/2006 | EP1268609B1 Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 05/17/2006 | EP1240518A4 Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors |
| 05/17/2006 | EP1222300B1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 05/17/2006 | EP1214598B1 Screening for inhibitors of "paired helical filaments" |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1212438B1 Flax seed specific promoters |
| 05/17/2006 | EP1210414B1 Alkaline xyloglucanase from malbranchea |
| 05/17/2006 | EP1169460B1 Preparation of biologically active molecules |
| 05/17/2006 | EP1155146B1 Diagnostic and screening method for male infertility |
| 05/17/2006 | EP1155122B1 ISOLATION AND CHARACTERIZATION OF A $i(N. CRASSA) SILENCING GENE AND USES THEREOF |
| 05/17/2006 | EP1141373B1 Method for the enantioselective and regioselective reduction of 3,5-dioxocarboxylic acids, their salts and their esters |
| 05/17/2006 | EP1141368B1 Method for producing ascorbic acid intermediates |
| 05/17/2006 | EP1135515B1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 05/17/2006 | EP1124853B1 Anti-petasin antibodies, methods for the production thereof and their use |
| 05/17/2006 | EP1117693B1 Intein mediated peptide ligation |
| 05/17/2006 | EP1109914B1 Heme oxygenase 1 for the inhibition of smooth muscle cell migration |
| 05/17/2006 | EP1088233B9 A bioluminescence resonance energy transfer (bret) system and its use |
| 05/17/2006 | EP1067183B1 Novel g protein-coupled receptor proteins |
| 05/17/2006 | EP1048727B1 Gene encoding novel transmembrane protein |
| 05/17/2006 | EP1029064B1 Protein production in transgenic alfalfa plants |
| 05/17/2006 | EP1025245B1 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | EP0973391B1 Endoderm, cardiac and neural inducing factors |